Founder Intelligence

Avak Kahvejian

Advancing technology at Generate Biomedicines requires rigorous software engineering, disciplined execution, and solving real operational bottlenecks for enterprise users.

Role
Founder
Country
United States
Company founded
2018
Status
Active

Known for

Generate Biomedicines provides enterprise-grade artificial intelligence solutions, delivering specialized Generate Biomedicines Platform technology designed to optimize…

Ecosystem Connection Map

How this founder connects across companies, products, industries, and research on Brel.

Overview

Structured founder intelligence — role, focus, and why this person matters in the AI ecosystem.

Based in United States, Avak Kahvejian leads product direction and operational execution as Founder at Generate Biomedicines.

Why it matters

Avak Kahvejian exemplifies the executive leadership required to bring complex technology platforms to market and support enterprise adoption at Generate Biomedicines.

Career & Timeline

Verified career context from this founder profile.

Career & Leadership

Avak Kahvejian brings disciplined engineering and executive experience to Generate Biomedicines, overseeing software development and enterprise customer deployments.

Industry & Technical Contributions

Under Avak Kahvejian's direction at Generate Biomedicines, technical teams have engineered robust, high-performance systems that solve mission-critical data and workflow demands.

  • Company founded 2018 · founded Generate Biomedicines was founded in 2018 per the company profile source on file. Source
  • 2018: Generate Biomedicines founded at Flagship Pioneering; Molly Gibson among co-founders. 2018 · development Source
  • January 2024: Generate expanded Amgen collaboration and reported first patient dosed in GB-0895 Phase 1. 2024 · development Source

Companies

Organizations connected to this founder in the Brel graph.

Products

Products and platforms linked to this founder or their organization.

  • Generate Platform Biotechnology

    Explore Generate Platform by Generate Biomedicines. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture...

    View product

Industries & Use Cases

Sectors and use cases connected to this founder profile.

Industries

Ecosystem

Partnerships, acquisitions, and adjacency signals from the connected company graph.

Partnerships

  • January 2024: Generate expanded Amgen collaboration and reported first patient dosed in GB-0895 Phase 1.

Latest Developments

Recent milestones from the connected organization.

  • 2025–2026: GB-0895 advanced toward global Phase 3 studies for severe asthma; Mike Nally continues as CEO. Latest
  • Development 2018 · development Source
  • Leadership 2025 · leadership Source

FAQ

Answers restated from verified fields on this profile.

Who is Avak Kahvejian?

Avak Kahvejian is a technology leader and entrepreneur currently serving as Founder at Generate Biomedicines.

What company is Avak Kahvejian associated with?

Avak Kahvejian is associated with Generate Biomedicines, leading product and technical initiatives.

Where is Avak Kahvejian based?

Avak Kahvejian is based in United States.

What are Avak Kahvejian's key contributions to the industry?

Avak Kahvejian focuses on scalable software architecture, enterprise product development, and applied artificial intelligence leadership at Generate Biomedicines.

Sources & Verification

Verified
Last reviewed Aug 2026

Primary sources

In this profile